These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35212542)

  • 1. Design, Synthesis, and Bioevaluation of 2-Aminopteridin-7(8
    Yu F; Zhu C; Ze S; Wang H; Yang X; Liu M; Xie Q; Lu W; Wang Y
    J Med Chem; 2022 Mar; 65(5):4367-4386. PubMed ID: 35212542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of Pyridinone Derivatives as Potent, Selective, and Orally Bioavailable Adenosine A
    Zhu C; Ze S; Zhou R; Yang X; Wang H; Chai X; Fang M; Liu M; Wang Y; Lu W; Xie Q
    J Med Chem; 2023 Apr; 66(7):4734-4754. PubMed ID: 36951370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A
    Kjaergaard J; Hatfield S; Jones G; Ohta A; Sitkovsky M
    J Immunol; 2018 Jul; 201(2):782-791. PubMed ID: 29802128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenosine A
    Yu F; Zhu C; Xie Q; Wang Y
    J Med Chem; 2020 Nov; 63(21):12196-12212. PubMed ID: 32667814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and biological evaluation of novel scaffold benzo[4,5]imidazo [1,2-a]pyrazin-1-amine: Towards adenosine A
    Reddy GL; Sarma R; Liu S; Huang W; Lei J; Fu J; Hu W
    Eur J Med Chem; 2021 Jan; 210():113040. PubMed ID: 33316692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A2A adenosine receptor antagonists to weaken the hypoxia-HIF-1α driven immunosuppression and improve immunotherapies of cancer.
    Hatfield SM; Sitkovsky M
    Curr Opin Pharmacol; 2016 Aug; 29():90-6. PubMed ID: 27429212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of (4E)-4-(4-substitutedbenzylideneamino)-3-substituted-2,3-dihydro-2-thioxothiazole-5-carbonitrile as novel A2A receptor antagonists.
    Mishra CB; Sharma D; Prakash A; Kumari N; Kumar N; Luthra PM
    Bioorg Med Chem; 2013 Oct; 21(19):6077-83. PubMed ID: 23953686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Quinazoline Derivatives as Highly Effective A2A Adenosine Receptor Antagonists.
    Laversin A; Dufossez R; Bolteau R; Duroux R; Ravez S; Hernandez-Tapia S; Fossart M; Coevoet M; Liberelle M; Yous S; Lebègue N; Melnyk P
    Molecules; 2024 Aug; 29(16):. PubMed ID: 39202926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligand-activation of the adenosine A2a receptors inhibits IL-12 production by human monocytes.
    Link AA; Kino T; Worth JA; McGuire JL; Crane ML; Chrousos GP; Wilder RL; Elenkov IJ
    J Immunol; 2000 Jan; 164(1):436-42. PubMed ID: 10605040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting adenosine A
    Congreve M; Brown GA; Borodovsky A; Lamb ML
    Expert Opin Drug Discov; 2018 Nov; 13(11):997-1003. PubMed ID: 30336706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and biological evaluation of Tozadenant analogues as adenosine A
    Renk DR; Skraban M; Bier D; Schulze A; Wabbals E; Wedekind F; Neumaier F; Neumaier B; Holschbach M
    Eur J Med Chem; 2021 Mar; 214():113214. PubMed ID: 33548636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-regulation of carbon monoxide and the adenosine A2a receptor in macrophages.
    Haschemi A; Wagner O; Marculescu R; Wegiel B; Robson SC; Gagliani N; Gallo D; Chen JF; Bach FH; Otterbein LE
    J Immunol; 2007 May; 178(9):5921-9. PubMed ID: 17442976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenosine A2A-receptor stimulation inhibits lipopolysaccharide-induced interleukin-18 production in monocytes.
    Takahashi HK; Kanke T; Liu K; Yoshino T; Sendo T; Tanaka N; Nishibori M
    J Pharmacol Sci; 2007 Jun; 104(2):183-6. PubMed ID: 17558181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, and biological evaluation of triazole-pyrimidine-methylbenzonitrile derivatives as dual A
    Li Z; Kou L; Fu X; Xie Z; Xu M; Guo L; Lin T; Gong S; Zhang S; Liu M
    J Enzyme Inhib Med Chem; 2022 Dec; 37(1):1514-1526. PubMed ID: 35616298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The adenosine A
    Franco R; Lillo A; Navarro G; Reyes-Resina I
    Expert Opin Ther Targets; 2022 Sep; 26(9):791-800. PubMed ID: 36300278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the A2AR in cancer; early lessons from the clinic.
    Willingham SB; Hotson AN; Miller RA
    Curr Opin Pharmacol; 2020 Aug; 53():126-133. PubMed ID: 33002857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged exposure to 5'-N-ethylcarboxamidoadenosine (NECA) does not affect the adenosine A2A-mediated vasodilation in porcine coronary arteries.
    Conti A; Lozza G; Monopoli A
    Pharmacol Res; 1997 Feb; 35(2):123-8. PubMed ID: 9175581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of adenosine A2A receptor enhances CD8
    Ma SR; Deng WW; Liu JF; Mao L; Yu GT; Bu LL; Kulkarni AB; Zhang WF; Sun ZJ
    Mol Cancer; 2017 Jun; 16(1):99. PubMed ID: 28592285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of Novel Benzo[4,5]imidazo[1,2-
    Liu S; Ding W; Huang W; Zhang Z; Guo Y; Zhang Q; Wu L; Li Y; Qin R; Li J; Shi T; Zhang X; Lei J; Hu W
    J Med Chem; 2022 Jul; 65(13):8933-8947. PubMed ID: 35714367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel Antagonist of the Immune Checkpoint Protein Adenosine A2a Receptor Restores Tumor-Infiltrating Lymphocyte Activity in the Context of the Tumor Microenvironment.
    Mediavilla-Varela M; Castro J; Chiappori A; Noyes D; Hernandez DC; Allard B; Stagg J; Antonia SJ
    Neoplasia; 2017 Jul; 19(7):530-536. PubMed ID: 28582704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.